Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations section added with Illinois; Illinois Locations removed. HHS Vulnerability Disclosure link removed and revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe Publications section wording was updated to state that publications are automatically filled from PubMed and may not reflect the study; the revision number changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.4%

- Check100 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check107 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.